Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event Transcript

Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event Transcript#Novo #Nordisk #NOVOCA #Discusses #Obesity #Diabetes #Portfolio #Progress #Pill #Launch #Milestones #RampD #Event #Transcript